What is the success rate of stem cell therapy for Liver Cirrhosis?
No defensible pooled success rate exists. Review the exact cause and severity of cirrhosis, comparator, MELD or other validated measures, decompensation, transplant-free survival, adverse events and complete follow-up; a biochemical change alone is insufficient.
What the evidence shows for Liver Cirrhosis
Cell studies remain investigational and heterogeneous; changes in laboratory values must not be equated with survival, fewer decompensations or avoidance of transplantation. The NIDDK cirrhosis treatment guide emphasises treating the cause and complications, surveillance and liver-transplant assessment for liver failure. Experimental access should occur only through a verified protocol without delaying those measures.
Am I a candidate? → · Liver Cirrhosis: full overview → · Liver Cirrhosis cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Liver Cirrhosis: cell-therapy evidence and registered trials
- How much does stem cell therapy for Liver Cirrhosis cost? (2026)
- Liver Cirrhosis stem cell therapy — your questions answered (2026)
- Liver Cirrhosis: cell-therapy evidence by therapy class
- MSC vs HSCT for Liver Cirrhosis: what the registries show